FDA Approves Treatment for COVID-19 in Adults

Posted on May 26, 2023   |   

On May 25, 2023 the U.S. Food and Drug Administration (FDA) approved the first oral antiviral pill to treat mild-to-moderate COVID-19 in adult patients who have underlying conditions or are at high risk of complications from COVID.

This medication, called Paxlovid, was originally available under the emergency use authorization (EUA) and was made available through the U.S. Department of Health and Human Services. As of the writing of this post, the United States government will continue to make Paxlovid available to U.S. residents at no charge.

For more information about the approval of Paxlovid, please visit the FDA website or speak with your doctor or pharmacist.


You need to login to comment.
  • My husband, adult kids and I all had covid in July 2023 and since we all have asthma, were all prescribed paxlovid and all took it. We were all fortunate and had very mild cases and none of us needed to see or providers or had any long covid symptoms.

    My son did complain of a metallic taste while taking paxlovid but was still glad to have it to avoid getting long covid.